SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-008204
Filing Date
2019-03-18
Accepted
2019-03-18 19:03:32
Documents
2
Period of Report
2019-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4177
2 EX-24 DOCUMENT attachment1.htm EX-24 4142
  Complete submission text file 0000899243-19-008204.txt   10044
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Issuer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SELLAS LIFE SCIENCES GROUP, INC. 2000 CROW CANYON PLACE, STE. 380 SAN RAMON CA 94583
Business Address
Sarlis Nicholas J. (Reporting) CIK: 0001724151 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 19689767